WLF Will Use FDA Notice On Circuit Court Ruling As Wedge To Reopen Case

FDA's intention to use journal reprints distributed for off-label indications as evidence in misbranding enforcement actions violates the standing injunction on two "enduring materials" guidance documents, the Washington Legal Foundation contends.

More from Archive

More from Medtech Insight